IN-DATE
JADA-2002: Organon Jada Vacuum-Induced Postpartum Hemorrhage Control
Sign in to add this product to your favorites!
| Price: | $599.00 per kit |
|---|---|
| In Stock: | 0 kits |
| Expiration: | In-Date |
| Express: | Need it tomorrow? Order in next 2 hours 32 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
We currently do not have this item in stock, but we can email you as soon as it is available.
Related Items
QUICK VIEW
| JADA-1001 $599.00 EACH Organon Jada Vacuum-Induced Hemorrhage Control (No Box) In-Date Out of Stock |
QUICK VIEW
| G24237 $445.00 EACH Cook Bakri Postpartum Balloon w/Rapid Instillation: 24F / 54cm, 500ml (No Box) Exp: 01-2027 Units in stock: 2 | Order Qty |
QUICK VIEW
| JADA-2001 $595.00 EACH Organon Jada Vacuum-Induced Postpartum Hemorrhage Control, Device Only (No Box) In-Date Out of Stock |
QUICK VIEW
| G24237 $449.00 per box of 1 Cook Bakri Postpartum Balloon w/Rapid Instillation: 24F / 54cm, 500ml Exp: 05-2026 (or later) Units in stock: 27 box of 1 | Order Qty |
QUICK VIEW
| G48149 $45.00 EACH Cook Cervical Ripening Balloon 18F x 40cm Exp: 02-2026 (or later) Units in stock: 41 | Order Qty |
QUICK VIEW
| G19891-SD $289.99 per box of 10 Cook Cervical Ripening Balloon w/Stylet 18F x 40cm Exp: 08-2025 Units in stock: 5 box of 10 | Order Qty |
|
QUICK VIEW
| G19891 $45.00 EACH Cook Cervical Ripening Balloon w/Stylet 18F x 40cm Exp: 06-2026 (or later) Units in stock: 77 | Order Qty |
|
QUICK VIEW
| G48149-SD $34.99 EACH Cook Cervical Ripening Balloon 18F x 40cm Exp: 08-2025 Units in stock: 6 | Order Qty |
Additional Details
Organon Jada Vacuum-Induced Postpartum Hemorrhage Control
Item # JADA-2002
- Vacuum-Induced Hemorrhage Control System
- Luer-Lock Syringe 60ml
- Universal Vacuum Tubing 1/4" x 12'
Manufacturer
Organon is a global healthcare company that focuses on women's health, biosimilars, and medicines for other unmet medical needs. It was spun off from Merck & Co. in 2021 and operates as an independent entity. Organon’s portfolio includes contraceptive products, fertility treatments, biosimilar medicines, and women's health therapies. The company is well known for offering products that address hormonal therapies, gynecological conditions, and family planning. Organon also has a growing focus on biosimilars in oncology and immunology. By focusing on improving health outcomes for women and addressing unmet medical needs, Organon strives to provide accessible, affordable healthcare solutions globally.
